Product Information
Name:FDI-6
Brand:Biosynth
Description:FDI-6 is a novel anti-cancer prodrug that is activated by the enzyme cytochrome p450. It has been shown to induce apoptotic cell death in hematopoietic cells and cancer cells, as well as inhibit the growth of hepatocellular carcinoma (HCC) cells. FDI-6 induces apoptotic cell death in hematopoietic cells by stimulating the mitochondrial pathway of apoptosis and inhibiting mitochondrial membrane permeability. FDI-6 also inhibits HCC cells by inducing apoptosis and increasing the levels of reactive oxygen species (ROS) in these cancerous cells.FDI-6 has been shown to be effective against chemotherapy resistant cancer cells due to its ability to induce DNA damage. FDI-6 also has a beneficial effect on biochemical markers of metabolic disorders such as hypertriglyceridemia and hypercholesterolemia, suggesting that it may have therapeutic potential for treating these diseases.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:437.43 g/mol
Formula:C19H11F4N3OS2
Purity:Min. 95%
Technical inquiry about: FDI-6
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.